1). Vallon KR, Foti ME, Langman-Dorwart N, Gatti E. Comprehensive case management in the private sector for patients with severe mental illness. Psychiatr Serv. 1997; 48:910–914.
2). Holloway F, Oliver N, Collins E, Carson J. Case management: A critical review of the outcome literature. Eur Psychiatry. 1995; 10:113–128.
Article
3). 보건복지부 건강정책국 정신건강정책과. 2015년 정신건강사업 안내. 서울; 보건복지부;2015. 4) 정영철. 결정적 시기의 정신분열병 환자를 위한 정신사회적 중재. 초판. 서울: 학지사; 서울;2008.
5). Seoul Mental Health Center. TWO STEP: Social Treatment for Early Psychosis Program. Seoul. 2011.
6). Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998; 172:53–59.
7). McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry. 2002; 1:76–83.
8). Álvarez-Jiménez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Killackey E, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in firstepisode psychosis over 7.5 years. Psychol Med. 2012; 42:595–606.
Article
9). Nelson B, Philips LJ, Bechdolf A, Francey SM. Cognitive Behav-ioural Case Management (CBCM) for the NEURAPRO-E study. Version 1. Orygen Youth Health: Melbourne;2008.
10). Thompson AD. The PACE Clinic Manual: A Treatment Approach for Young People at Ultra High Risk of Psychosis. Orygen Youth Health: Melbourne;2012.
11). Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, et al. NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behav-ioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Interv Psychiatry 2015 [Epub ahead of print].
12). Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale for schzophrenia. Schizophr Bull. 1987; 13:261–276.
13). Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatr Assoc. 2001; 40:1090–1105.
14). Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Devel opment, reliability and acceptability of a new version of the DSMIV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000; 101:323–329.
15). Lee JG, Seok JH, Lee JY, Lee KU, Kwak KH, Kwon JS, et al. A validation study of the Korean-version of the Personal and Social Performance scale. Korean J Psychopharmacol. 2006; 17:497–506.
16). Mizrahi R. Social Stress and Psychosis Risk: Common Neurochemical Substrates? Neuropsychopharmacology. 2016; 41:666–74.
Article
17). Edwards J, Cocks J, Bott J. Preventive case management in firstepisode psychosis. McGorry PD, Jackson HJ, editors. The recognition and management of early psychosis. A preventive approach. Cambridge: Cambridge University Press;1999.
18). Evans-Jones C, Peters E, Barker C. The therapeutic relationship in CBT for psychosis: client, therapist and therapy factors. Behav Cogn Psychother. 2009; 37:527–540.
Article